VISANI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 720
EU - Europa 363
AS - Asia 74
AF - Africa 1
Totale 1.158
Nazione #
US - Stati Uniti d'America 715
IT - Italia 128
IE - Irlanda 80
SE - Svezia 59
PL - Polonia 58
JO - Giordania 21
CN - Cina 18
HK - Hong Kong 16
AT - Austria 14
SG - Singapore 8
DE - Germania 7
BE - Belgio 6
GB - Regno Unito 5
CA - Canada 4
IN - India 4
JP - Giappone 2
PH - Filippine 2
RU - Federazione Russa 2
UA - Ucraina 2
VN - Vietnam 2
CZ - Repubblica Ceca 1
GL - Groenlandia 1
GR - Grecia 1
NG - Nigeria 1
TH - Thailandia 1
Totale 1.158
Città #
Fairfield 95
Chandler 87
Dublin 80
Ashburn 79
Warsaw 58
Woodbridge 54
Houston 46
Seattle 43
Cambridge 41
Ann Arbor 38
Wilmington 35
Dearborn 25
Lawrence 24
Altamura 22
Florence 20
Milan 13
Princeton 13
Buffalo 12
Beijing 9
Boston 9
Medford 9
Vienna 9
Rome 7
San Diego 7
Brussels 6
San Quirino 4
Cambiago 3
Fontebuona 3
London 3
Pontedera 3
Redwood City 3
Toronto 3
Viterbo 3
Boardman 2
Campi Bisenzio 2
Cervignano del Friuli 2
Dong Ket 2
Empoli 2
Falls Church 2
Fiesole 2
Hillsboro 2
Lonate Ceppino 2
Nagold 2
Nanjing 2
Norwalk 2
Pavia 2
Scarperia e San Piero 2
Trecate 2
Andover 1
Arezzo 1
Bologna 1
Boscoreale 1
Brescia 1
Cabanatuan City 1
Chengdu 1
Delhi 1
Falkenstein 1
Gorgonzola 1
Guangzhou 1
Hangzhou 1
Hefei 1
Kumar 1
Lagos 1
Lucca 1
Nardò 1
New Bedfont 1
Nuuk 1
Phoenix 1
Piraeus 1
Ponte Buggianese 1
Prague 1
Pune 1
Quezon City 1
Stockholm 1
Thiene 1
Turin 1
Verona 1
Wuhan 1
Totale 926
Nome #
Efficacy and tolerability of cyberknife stereotactic robotic radiotherapy for primary or secondary orbital lesions: A single-center retrospective experience 152
Influence of age and subtype in outcome of operable liposarcoma 115
PO-0643: Scalp-sparing radiotherapy to minimize alopecia in patients with primary brain cancer 107
A matched cohort study of radio-chemotherapy versus radiotherapy alone in soft tissue sarcoma patients 99
Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 – EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures 96
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 88
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 81
Re-irradiation as salvage treatment in recurrent glioblastoma: A comprehensive literature review to provide practical answers to frequently asked questions 71
Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study 71
Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases 54
Cardioprotective Strategy for Patients with Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial 46
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275) 39
Is there a worthwhile value in personalizing radiation therapy for breast cancer patients? Time for a new paradigm in the older adult population 30
Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with previous breast irradiation and post-mastectomy radiation therapy 29
Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside 27
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy 22
Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer 19
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894) 11
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort 6
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 5
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: a systematic review and meta-analysis 5
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 5
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis 5
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 3
Totale 1.186
Categoria #
all - tutte 3.812
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.812


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201954 0 0 0 0 0 1 2 3 0 11 19 18
2019/2020296 10 18 5 18 50 42 40 29 30 17 22 15
2020/2021155 16 8 6 24 4 15 7 10 18 18 12 17
2021/2022129 3 9 9 8 4 4 7 18 8 4 17 38
2022/2023406 26 86 33 8 22 70 56 38 48 3 13 3
2023/2024140 17 25 28 24 24 22 0 0 0 0 0 0
Totale 1.186